Abdul Mageed Abdul Fattah Muhamad Algendy is an interventional cardiologist based in Baltimore, Maryland and Cairo, Egypt. He has over 25 years of experience, including positions as a consultant, trainer, and senior registrar in Egypt, France, and the United States. He specializes in procedures like percutaneous coronary intervention (PCI), stenting, pacemaker implantation, and valvuloplasty.
Preliminary Scientific Program of 2018 Healthcare and Cardiology ConferenceTerresa Lisbon
2018 Healthcare and Cardiology Conference (2018HCC) program is presented through a variety of sessions including keynote lectures, session speeches, young investigator sessions and poster presentations where international experts are invited to deliver lively discussions on sub-specialty topics on healthcare, cardiology, and cardiac surgery. It includes presentations of the best abstracts. Scientific sessions are held from Tuesday, September 18 to Wednesday, September 19, 2018. Cardiology Congress sessions are geared toward participants with different levels of experience and different positions. You may attend the sessions of your choice. The congress registration fee includes access to all scientific sessions.
Preliminary Scientific Program of 2018 Healthcare and Cardiology ConferenceTerresa Lisbon
2018 Healthcare and Cardiology Conference (2018HCC) program is presented through a variety of sessions including keynote lectures, session speeches, young investigator sessions and poster presentations where international experts are invited to deliver lively discussions on sub-specialty topics on healthcare, cardiology, and cardiac surgery. It includes presentations of the best abstracts. Scientific sessions are held from Tuesday, September 18 to Wednesday, September 19, 2018. Cardiology Congress sessions are geared toward participants with different levels of experience and different positions. You may attend the sessions of your choice. The congress registration fee includes access to all scientific sessions.
The mechanisms involved in the progression of heart failure includes cardiomyocyte death, initiation of the inflammatory response, and subsequent formation of a fibrotic scar. For this reason, diverse experimental models, such as cultured cardiac cells, isolated hearts, and animal models, have been created to mimic human myocardial infarction and heart failure. In a 2012 Scientific Statement from the American Heart Association, permanent coronary artery ligation was deemed clinically relevant and a significant model for ischemic heart failure.
The variability in coronary artery anatomy and branching of the left coronary artery can affect reproducibility of MI surgery, even with occlusion at a constant anatomic site. Blanching and LV discoloration are common variables used to confirm successful MI surgery. Determining a way to improve precision will improve the standard surgical approaches to simulate MI in mice, thus reducing the number of experimental animals necessary for statistically relevant studies. In this webinar, we will discuss the advantages of using electrocardiography to verify correct ligation.
Learning objections
Summary of my lab goals
Timeline of inflammation after permanent occlusion
Intro to MI surgical model
How do we as anesthesiologists address the need for acute pain medicine physicians and have a positive impact on the patient experience? We can take the lead in developing multimodal perioperative pain management protocols. Anesthesiologists can also add value through cost savings for the hospital. More effective pain management can prevent inadvertent admissions or readmissions due to pain. In addition, an effective multimodal analgesic protocol can directly or indirectly prevent hospital-acquired conditions (HACs). HACs are considered by CMS to be “never events” and supposedly preventable (4); hospitals reporting HACs as secondary diagnoses are not entitled to Medicare or Medicaid payments for related care.
The mechanisms involved in the progression of heart failure includes cardiomyocyte death, initiation of the inflammatory response, and subsequent formation of a fibrotic scar. For this reason, diverse experimental models, such as cultured cardiac cells, isolated hearts, and animal models, have been created to mimic human myocardial infarction and heart failure. In a 2012 Scientific Statement from the American Heart Association, permanent coronary artery ligation was deemed clinically relevant and a significant model for ischemic heart failure.
The variability in coronary artery anatomy and branching of the left coronary artery can affect reproducibility of MI surgery, even with occlusion at a constant anatomic site. Blanching and LV discoloration are common variables used to confirm successful MI surgery. Determining a way to improve precision will improve the standard surgical approaches to simulate MI in mice, thus reducing the number of experimental animals necessary for statistically relevant studies. In this webinar, we will discuss the advantages of using electrocardiography to verify correct ligation.
Learning objections
Summary of my lab goals
Timeline of inflammation after permanent occlusion
Intro to MI surgical model
How do we as anesthesiologists address the need for acute pain medicine physicians and have a positive impact on the patient experience? We can take the lead in developing multimodal perioperative pain management protocols. Anesthesiologists can also add value through cost savings for the hospital. More effective pain management can prevent inadvertent admissions or readmissions due to pain. In addition, an effective multimodal analgesic protocol can directly or indirectly prevent hospital-acquired conditions (HACs). HACs are considered by CMS to be “never events” and supposedly preventable (4); hospitals reporting HACs as secondary diagnoses are not entitled to Medicare or Medicaid payments for related care.
1. ABDUL MAGEED ABDUL FATTAH MUHAMAD
ALGENDY.
117 Old House Court , Baltimore ,Maryland , 21208 . USA
20 Nobar St., Abdeen, Cairo, Egypt
Tel.: 410-653-9573. (USA) Fax: 410-653-9571.
Cell: 443-854-7908. (USA)
TEL.: 741-4888. (EGYPT) Fax: 010-535-0787.
CELL: 010-535-1514. (EGYPT)
E-mail: elgendy33@hotmail.com (Preferred )
Abdulmageed22@aim.com
Certificates:
1 - American Board of Interventional Cardiology.
Year: 2000.
2 - Doctorate Degree in Cardiovascular Medicine & Interventional
Cardiology.
University: Ain Shams – Cairo.
Year: 2001.
3 – Diplomat of Interventional Cardiology.
University: Universite D’Auvergne – France.
Year: 1999.
4 - Master Degree in Cardiovascular Medicine.
University: Cairo University.
Year: May, 1996.
5 - M.B.B.Ch. (Medical Bachelor & Bachelor of Cherurgie)
University: Cairo University.
Year: June, 1990.
Training:
1 - Training Program in PCI and Stent Applications.
Johns Hopkins University – Maryland – USA.
Period: September 1996 - September 1998.
2 - PCI and Carotid Stent Applications.
University D’Auvergne - France.
Period: May 1999 - June 1999.
2. Professional Experience:
1 - Consultant of Interventional Cardiology.
National Heart Institute - Cairo - Egypt.
Period: April 2000 - till now.
Duties & Responsibilities:
-Conducted 700 cases PCI & Stenting as an operator distributed
As 200 with single vessel disease, 300 with two vessels disease,
150 with triple vessels disease and 50 with left Main Coronary
Artery Disease.
-Conducted 200 cases as an operator of Balloon Mitral
Valvuloplasty using the Inoe Balloon, Multitrack, and
Conventional Balloons.
-Conducted 45 cases of Balloon Pulmonary Valvuloplasty using
Conventional Balloons.
-Conducted 75 cases of Permanent Pacemaker between Single
And Dual Chamber Pacing.
NB: All cases were conducted on Philips, General Electric or
XRE Catheterization Machines.
2 - Consultant of Interventional Cardiology.
Union Memorial Hospital - Baltimore - Maryland.
Period: April 2001 - 2003.
Duties & Responsibilities:
-Conducted 1150 cases of PCI & Stenting as an operator
Distributed as 300 with single vessel disease, 250 with two
Vessels disease, 450 with triple vessels disease and 150 cases
With left main coronary artery disease.
-Conducted 100 cases as an operator of Permanent Pacemaker
Between Single and Dual Chamber Pacing.
-Conducted 5 cases of AICD implantation.
NB: All cases were conducted on General Electric and Siemens
Toshiba Catheterization Machines.
3 - Consultant Expert of Interventional Cardiology.
As-Salam International Hospital - Cairo - Egypt.
Period: June 2000 - till now.
Duties & Responsibilities:
-Conducted 210 cases of PCI & Stenting as an operator between
Single and Multivessels diseases including 7 cases of Left Main
Coronary Artery Diseases.
3. -Conducted 12 cases as an operator of Permanent Single
Chamber Pacemaker and 3 cases of Dual Chamber Pacemaker.
NB: All cases were conducted on Toshiba Catheterization
Machine.
4- Trainer.
Universite D’Auvergne.
Period: May 1999 - June 1999.
Duties & Responsibilities:
-Conducted 60 cases of PCI & Stenting as 1st assistant between
Single, dual & Multivessels diseases.
NB: All cases were conducted on Siemens and Toshiba
Catheterization Machines.
5- Senior Registrar.
National Heart Institute - Cairo - Egypt.
Period: 1998 - 1999.
Duties & Responsibilities:
-Conducted 120 cases as an operator and 1st assistant of PCI
Between single and dual vessels diseases, and Coronary
Angiography.
-Conducted 17 cases as an operator of Permanent Pacemaker
6 of them were re-do.
-Conducted 18 cases of Balloon Mitral Valvuloplasty as well as
5 cases of Balloon Pulmonary Valvuloplasty.
-Conducted 20 cases of diagnostic Congenital Heart Diseases.
NB: All cases were conducted on General Electric
Catheterization Machines.
6- Cardiologist.
Johns Hopkins University - Maryland - USA.
Period: 1996 - 1998.
Duties & Responsibilities:
-Conducted 630 cases of PCI & Stent between Single, Dual and
Multivessels Diseases.
NB: All cases were conducted on General Electric and Toshiba
Catheterization Machines.
7- PGY 3.
South Sinai Hospital - New Jersey - USA.
Period: March 1995 – March 1996.
Duties & Responsibilities:
4. -Conducted 260 cases as 1st and 2nd assistant of Coronary
Angiography and PCI.
-Conducted 500 cases of Post Catheterization Assessment
And Outpatient Clinics Follow-up.
8- PGY 2.
South Sinai Hospital - New Jersey - USA.
Period: March 1994 - March 1995.
Duties & Responsibilities:
-Conducted 600 cases between Inpatient Care in Cardiology
Department Wards and Outpatient Clinics, Exercise Testing,
EchoDoppler Assessment and Nuclear Cardiac Imaging.
9- PGY 1.
South Sinai Hospital - New Jersey - USA.
Period: March 1993 - March 1994.
Duties & Responsibilities:
The same as PGY 2 nearly.
10 - PGY 1.
Dar Al Chifa Hospital - Cairo - Egypt.
Period: 1992.
Duties & Responsibilities:
-Conducted 300 cases of PCI as 2nd and then 1st assistant.
-Conducted 500 cases inpatient as a resident of variable
Cardiovascular diseases.
-Conducted 270 cases in CCU as a resident.
11 - Chief Department, Egyptian Cabinet CCU, specialized
For the Prime and whole Egyptian Ministers.
Egyptian Cabinet of Ministers.
Period: 2003 – till now.
Honors & Grants:
1 - Grant of Swiss National Foundation & Pfizer for the Project
Entitled “Influence of Hormones on Blood Pressure & Arte-
Rial wall”.
Year: 2000.
2 - Prix De La Fondation Pour La Promotion De L’Eenseignement
Et De La Recherché En Cardiologie.
Year: 1999.
3 - Award of the Johns Hopkins, School of Medicine, for the
5. Thesis entitled “Effect of Bee Honey & Dates on Atheroscl-
erosis And healthy Endothelium”.
Year: 1997.
4 - Award for Young Investigator, Swiss National Foundation.
Year: 1997.
Inventions:
1 - New Aortic (Pediatric & Adult) Balloon Set, dealing
With Aortic Valvuloplasty (Applying for Patent Registry
US Patent Office).
2 - Owner of New Guide wire dealing with Coronary Angio-
Plasty.
Professional Societies:
1 - Member of American College of Interventional Cardiology.
2 - Member of American College of Cardiology.
3 - Member of American Society of Hypertension.
4 - Member of European Society of Cardiology.
5 - Member of Egyptian Society of Cardiology.